Veritas Investment Partners (Uk) Ltd. Abb Vie Inc. Transaction History
Veritas Investment Partners (Uk) Ltd.
- $5 Billion
- Q1 2025
A detailed history of Veritas Investment Partners (Uk) Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Veritas Investment Partners (Uk) Ltd. holds 1,185 shares of ABBV stock, worth $221,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,185
Previous 1,935
38.76%
Holding current value
$221,346
Previous $343,000
27.7%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
4,271Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32.5 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.2 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.69 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $330B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...